全文获取类型
收费全文 | 5688篇 |
免费 | 554篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 121篇 |
儿科学 | 243篇 |
妇产科学 | 108篇 |
基础医学 | 719篇 |
口腔科学 | 142篇 |
临床医学 | 558篇 |
内科学 | 1173篇 |
皮肤病学 | 78篇 |
神经病学 | 406篇 |
特种医学 | 347篇 |
外国民族医学 | 1篇 |
外科学 | 835篇 |
综合类 | 221篇 |
一般理论 | 2篇 |
预防医学 | 481篇 |
眼科学 | 60篇 |
药学 | 534篇 |
中国医学 | 3篇 |
肿瘤学 | 269篇 |
出版年
2021年 | 81篇 |
2020年 | 61篇 |
2019年 | 73篇 |
2018年 | 109篇 |
2017年 | 112篇 |
2016年 | 131篇 |
2015年 | 118篇 |
2014年 | 197篇 |
2013年 | 238篇 |
2012年 | 282篇 |
2011年 | 271篇 |
2010年 | 198篇 |
2009年 | 215篇 |
2008年 | 256篇 |
2007年 | 317篇 |
2006年 | 245篇 |
2005年 | 226篇 |
2004年 | 189篇 |
2003年 | 161篇 |
2002年 | 178篇 |
2001年 | 171篇 |
2000年 | 176篇 |
1999年 | 133篇 |
1998年 | 120篇 |
1997年 | 91篇 |
1996年 | 101篇 |
1995年 | 86篇 |
1994年 | 66篇 |
1993年 | 70篇 |
1992年 | 104篇 |
1991年 | 89篇 |
1990年 | 82篇 |
1989年 | 103篇 |
1988年 | 92篇 |
1987年 | 112篇 |
1986年 | 97篇 |
1985年 | 82篇 |
1984年 | 59篇 |
1983年 | 58篇 |
1982年 | 40篇 |
1980年 | 47篇 |
1979年 | 55篇 |
1978年 | 49篇 |
1977年 | 41篇 |
1976年 | 41篇 |
1975年 | 49篇 |
1974年 | 39篇 |
1973年 | 36篇 |
1972年 | 32篇 |
1970年 | 36篇 |
排序方式: 共有6301条查询结果,搜索用时 31 毫秒
991.
Jin-Xin Zhao Yu-Xuan Chang Chi He Benjamin J. Burke Michael R. Collins Matthew Del Bel Jeff Elleraas Gary M. Gallego T. Patrick Montgomery James J. Mousseau Sajiv K. Nair Matthew A. Perry Jillian E. Spangler Julien C. Vantourout Phil S. Baran 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(28)
992.
Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior 总被引:8,自引:0,他引:8
Michael G. House M.D. MingZhou Guo M.D. Ph.D. David T. Efron M.D. Keith D. Lillemoe M.D. John L. Cameron M.D. James E. Syphard B.S. Craig M. Hooker M.P.H. Susan C. Abraham M.D. Elizabeth A. Montgomery M.D. James G. Herman M.D. Malcolm V. Brock M.D. 《Journal of gastrointestinal surgery》2003,7(8):1004-1014
The growing understanding of the epigenetic changes associated with cancer, including aberrant promoter methylation of tumor
suppressor genes that afford selective growth advantages to human neoplasms, suggests that the characterization of gene methylation
patterns among gastrointestinal stromal tumors (GISTs) may be useful for predicting tumor behavior. Thirty-eight c-kit-positive
gastric stromal tumors were subjected to methylation-specific polymerase chain reaction (MSP) to detect promoter methylation
associated with 11 candidate tumor suppressor genes (p16/INK4a, APC, MGMT, hMLH1, p73, E-cadherin, RAR-β, RASSF1A, RB, ER, and DAPK), established to have a role in tumorigenesis of several solid human organs. Aberrant methylation of any of the 11 candidate
tumor suppressor genes was detected in 84% of all GISTs. In decreasing order of frequency, the six most commonly methylated
genes were: MGMT (47%), p16 (45%), RASSF1A (40%), E-cadherin (37%), hMLH1 (34%), and APC (31%). For all of the GISTs, promoter methylation was less reliable than tumor mitotic rate in predicting 5-year tumor-free
survival for the GISTs; however, E-cadherin methylation was a multivariate prognostic factor for early recurrence of GISTs (50% at 2 years; P = 0.030). Among the mitotically active (>5 per 50 high-power field), histologically indistinguishable GISTs, E-cadherin methylation was an independent predictor of tumor-related mortality: 5-year disease-free survival was worse for the E-cadherin methylated GISTs (19%) compared to the E-cadherin unmethylated tumors (71%; P = 0.010). Detection of methylation within selected genes may afford a reliable and accurate molecular marker system for predicting
neoplastic behavior among GISTs. This study supports the methylation status of E-cadherin as a prognostic marker for early GIST recurrence and survival.
Presented at the Forty-Fourth Annual Meeting of The Society for Surgery of the Alimentary Tract, Orlando, Florida, May 17–22,
2003.
Supported in part by a grant from the Niarchos Surgical Research Fund of the Stavros S. Niarchos Foundation (M.G.H.) and National
Cancer Institute grant CA-84986 from the Early Detection Research Network (J.G.H.). 相似文献
993.
994.
995.
Kulkarni J Berk M Fitzgerald PB de Castella AR Montgomery W Kelin K Brnabic A Granger RE Dodd S 《Journal of affective disorders》2008,107(1-3):135-144
BACKGROUND: The Bipolar Comprehensive Outcomes Study (BCOS) is a 2-year, observational study of participants with bipolar I or schizoaffective disorder examining clinical, functional, and economic outcomes associated with naturalistic treatment. METHODS: Participants prescribed mood stabilisers were assessed using various measures, including the Young Mania Rating Scale (YMRS), 21-item Hamilton Depression Rating scale (HAMD21), Clinical Global Impressions-Bipolar Version Severity of Illness scale (CGI-BP), and the EuroQol instrument (EQ-5D). RESULTS: 240 participants were recruited from two sites. On average, participants were 41.8+/-12.7 years of age (mean+/-SD), 58.3% were female, and 73.3% had a diagnosis of bipolar I disorder at study entry. The majority of participants were moderately ill, with an average CGI-BP Overall score of 3.8+/-1.3. Most participants had subthreshold mania and depression symptoms, indicated by HAMD21 Total 13.4+/-8.6, CGI-BP Depression 3.2+/-1.3, YMRS Total 8.2+/-8.5 and CGI-BP Mania 3.0+/-1.6 average scores. For bipolar participants, 94.6% of hospitalisations for psychiatric treatment in the past 3 months were single admissions (vs. 65.2% for schizoaffective participants, p=.002). Bipolar participants rated their overall health state higher (EQ-5D scores: 68.2+/-18.8 vs. 61.6+/-22.7, p=.023), had a higher mean weekly wage ($500-$999, 21.3% vs. 6.3%), lower unemployment (22.2% vs. 48.4%), and higher romantic relationship status (47.1% vs. 26.6%). LIMITATIONS: The observational design and small sample size may have limited the causal relationships and generalisability within the current findings. CONCLUSIONS: Participants were characterised by social and occupational dysfunction at entry, but schizoaffective participants appeared to be more severely affected. Effective treatment is required to address both clinical and functional impairment. 相似文献
996.
997.
Benyamin B Perola M Cornes BK Madden PA Palotie A Nyholt DR Montgomery GW Peltonen L Martin NG Visscher PM 《European journal of human genetics : EJHG》2008,16(4):516-524
Most information in linkage analysis for quantitative traits comes from pairs of relatives that are phenotypically most discordant or concordant. Confounding this, within-family outliers from non-genetic causes may create false positives and negatives. We investigated the influence of within-family outliers empirically, using one of the largest genome-wide linkage scans for height. The subjects were drawn from Australian twin cohorts consisting of 8447 individuals in 2861 families, providing a total of 5815 possible pairs of siblings in sibships. A variance component linkage analysis was performed, either including or excluding the within-family outliers. Using the entire dataset, the largest LOD scores were on chromosome 15q (LOD 2.3) and 11q (1.5). Excluding within-family outliers increased the LOD score for most regions, but the LOD score on chromosome 15 decreased from 2.3 to 1.2, suggesting that the outliers may create false negatives and false positives, although rare alleles of large effect may also be an explanation. Several regions suggestive of linkage to height were found after removing the outliers, including 1q23.1 (2.0), 3q22.1 (1.9) and 5q32 (2.3). We conclude that the investigation of the effect of within-family outliers, which is usually neglected, should be a standard quality control measure in linkage analysis for complex traits and may reduce the noise for the search of common variants of modest effect size as well as help identify rare variants of large effect and clinical significance. We suggest that the effect of within-family outliers deserves further investigation via theoretical and simulation studies. 相似文献
998.
Swanson KD Winter JM Reis M Bentires-Alj M Greulich H Grewal R Hruban RH Yeo CJ Yassin Y Iartchouk O Montgomery K Whitman SP Caligiuri MA Loh ML Gilliland DG Look AT Kucherlapati R Kern SE Meyerson M Neel BG 《Genes, chromosomes & cancer》2008,47(3):253-259
Germ line gain-of-function mutations in several members of the RAS/ERK pathway, including PTPN11, KRAS, and RAF1, cause the autosomal dominant genetic disorder Noonan Syndrome (NS). NS patients are at increased risk of leukemia/myeloproliferative disease and possibly some solid tumors, such as neuroblastoma. Recently, SOS1 gain of function mutations have also been shown to cause NS. Somatic PTPN11, KRAS, and RAF1 mutations occur (although at different frequencies) in a variety of sporadic neoplasms, but whether SOS1 mutations are associated with human cancer has not been evaluated. We sequenced DNA from a total of 810 primary malignancies, including pancreatic, lung, breast, and colon carcinomas, and acute myelogenous leukemia, as well as several neuroblastoma cell lines. From this large, diverse series, missense SOS1 mutations were identified in a single pancreatic tumor, one lung adenocarcinoma, and a T-cell acute lymphoblastic leukemia cell line. Our findings suggest that SOS1 is not a significant human oncogene in most cancers. Furthermore, NS patients with SOS1 mutations may not be at increased risk of developing cancer. 相似文献
999.
1000.